Biomaxima (WAR:BMX) — Market Cap & Net Worth
Market Cap & Net Worth: Biomaxima (BMX)
Biomaxima (WAR:BMX) has a market capitalization of $11.48 Million (zł41.72 Million) as of August 4, 2026. Listed on the WAR stock exchange, this Poland-based company holds position #26669 globally and #287 in its home market, demonstrating a -1.87% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Biomaxima's stock price zł9.95 by its total outstanding shares 4193118 (4.19 Million). See how much does Biomaxima reinvest in capital to understand how much of operating cash flow is reinvested back into capital assets.
Biomaxima Market Cap History: 2015 to 2026
Biomaxima's market capitalization history from 2015 to 2026. Data shows growth from $4.43 Million to $11.48 Million (9.34% CAGR).
Biomaxima Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Biomaxima's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.23x
Biomaxima's market cap is 0.23 times its annual revenue
Latest Price to Earnings (P/E) Ratio
23.08x
Biomaxima's market cap is 23.08 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $4.43 Million | $21.97 Million | $1.45 Million | 0.20x | 3.05x |
| 2016 | $5.38 Million | $26.98 Million | $1.23 Million | 0.20x | 4.38x |
| 2017 | $5.60 Million | $31.57 Million | $805.68K | 0.18x | 6.95x |
| 2018 | $4.74 Million | $30.82 Million | -$481.98K | 0.15x | N/A |
| 2019 | $4.02 Million | $30.49 Million | -$13.51K | 0.13x | N/A |
| 2020 | $30.99 Million | $61.61 Million | $7.95 Million | 0.50x | 3.90x |
| 2021 | $29.80 Million | $79.09 Million | $10.24 Million | 0.38x | 2.91x |
| 2022 | $29.66 Million | $143.87 Million | $28.89 Million | 0.21x | 1.03x |
| 2023 | $18.95 Million | $46.79 Million | $586.00K | 0.41x | 32.34x |
| 2024 | $12.35 Million | $52.85 Million | $535.00K | 0.23x | 23.08x |
Competitor Companies of BMX by Market Capitalization
Companies near Biomaxima in the global market cap rankings as of August 4, 2026.
Key companies related to Biomaxima by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $215.77 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #169 globally with a market cap of $137.72 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #577 globally with a market cap of $46.48 Billion USD ( CN¥317.64 Billion CNY).
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #616 globally with a market cap of $43.83 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $215.77 Billion | $574.30 |
| #169 | Danaher Corporation | NYSE:DHR | $137.72 Billion | $194.98 |
| #577 | WuXi AppTec Co Ltd | SHG:603259 | $46.48 Billion | CN¥128.43 |
| #616 | IDEXX Laboratories Inc | NASDAQ:IDXX | $43.83 Billion | $559.07 |
Biomaxima Historical Marketcap From 2015 to 2026
Between 2015 and today, Biomaxima's market cap moved from $4.43 Million to $ 11.48 Million, with a yearly change of 9.34%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | zł11.48 Million | -17.43% |
| 2025 | zł13.91 Million | +12.62% |
| 2024 | zł12.35 Million | -34.84% |
| 2023 | zł18.95 Million | -36.11% |
| 2022 | zł29.66 Million | -0.47% |
| 2021 | zł29.80 Million | -3.84% |
| 2020 | zł30.99 Million | +670.96% |
| 2019 | zł4.02 Million | -15.17% |
| 2018 | zł4.74 Million | -15.43% |
| 2017 | zł5.60 Million | +4.13% |
| 2016 | zł5.38 Million | +21.34% |
| 2015 | zł4.43 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Biomaxima was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $11.48 Million USD |
| MoneyControl | $11.48 Million USD |
| MarketWatch | $11.48 Million USD |
| marketcap.company | $11.48 Million USD |
| Reuters | $11.48 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Biomaxima
BioMaxima S.A. produces and distributes microbiological media, reagents, and in vitro diagnostic equipment in Poland. It offers microbiology products, including ready to use media, such as plates, bottles, bags, and media in tubes; dehydrated media; agars and peptones; and supplements. The company also provides molecular biology and cell culture products which includes real time PCR, nucleic acid… Read more